Medtronic Pre-Tax Profit Margin 2012-2025 | MDT
Current and historical pre-tax profit margin for Medtronic (MDT) from 2012 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Medtronic pre-tax profit margin for the three months ending October 31, 2025 was .
| Medtronic Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-10-31 | $34.76B | $5.70B | 16.40% |
| 2025-07-31 | $34.20B | $5.66B | 16.56% |
| 2025-04-30 | $33.54B | $5.63B | 16.78% |
| 2025-01-31 | $33.20B | $5.22B | 15.73% |
| 2024-10-31 | $33.00B | $5.16B | 15.62% |
| 2024-07-31 | $32.58B | $4.91B | 15.07% |
| 2024-04-30 | $32.36B | $4.84B | 14.95% |
| 2024-01-31 | $32.32B | $5.53B | 17.11% |
| 2023-10-31 | $31.96B | $5.43B | 17.00% |
| 2023-07-31 | $31.56B | $5.52B | 17.48% |
| 2023-04-30 | $31.23B | $5.36B | 17.18% |
| 2023-01-31 | $30.77B | $5.42B | 17.60% |
| 2022-10-31 | $30.81B | $5.63B | 18.27% |
| 2022-07-31 | $31.07B | $5.73B | 18.44% |
| 2022-04-30 | $31.69B | $5.52B | 17.41% |
| 2022-01-31 | $31.79B | $5.48B | 17.24% |
| 2021-10-31 | $31.80B | $5.11B | 16.08% |
| 2021-07-31 | $31.60B | $4.14B | 13.12% |
| 2021-04-30 | $30.12B | $3.90B | 12.93% |
| 2021-01-31 | $27.93B | $2.53B | 9.07% |
| 2020-10-31 | $27.87B | $2.89B | 10.38% |
| 2020-07-31 | $27.93B | $3.66B | 13.11% |
| 2020-04-30 | $28.91B | $4.06B | 14.02% |
| 2020-01-31 | $31.06B | $5.14B | 16.55% |
| 2019-10-31 | $30.89B | $4.93B | 15.97% |
| 2019-07-31 | $30.67B | $4.99B | 16.29% |
| 2019-04-30 | $30.56B | $5.20B | 17.01% |
| 2019-01-31 | $30.56B | $5.63B | 18.43% |
| 2018-10-31 | $30.38B | $5.29B | 17.40% |
| 2018-07-31 | $29.95B | $5.66B | 18.90% |
| 2018-04-30 | $29.95B | $5.68B | 18.95% |
| 2018-01-31 | $29.73B | $5.39B | 18.12% |
| 2017-10-31 | $29.64B | $5.33B | 17.97% |
| 2017-07-31 | $29.93B | $4.81B | 16.07% |
| 2017-04-30 | $29.71B | $4.60B | 15.49% |
| 2017-01-31 | $29.36B | $4.30B | 14.65% |
| 2016-10-31 | $29.01B | $4.51B | 15.56% |
| 2016-07-31 | $28.73B | $4.38B | 15.26% |
| 2016-04-30 | $28.83B | $4.34B | 15.04% |
| 2016-01-31 | $28.57B | $3.39B | 11.86% |
| 2015-10-31 | $25.95B | $3.40B | 13.12% |
| 2015-07-31 | $23.26B | $3.34B | 14.37% |
| 2015-04-30 | $20.26B | $3.49B | 17.21% |
| 2015-01-31 | $17.52B | $3.78B | 21.57% |
| 2014-10-31 | $17.37B | $3.54B | 20.39% |
| 2014-07-31 | $17.20B | $3.64B | 21.14% |
| 2014-04-30 | $17.01B | $3.71B | 21.79% |
| 2014-01-31 | $16.90B | $4.38B | 25.91% |
| 2013-10-31 | $16.76B | $4.58B | 27.31% |
| 2013-07-31 | $16.67B | $4.32B | 25.90% |
| 2013-04-30 | $16.59B | $4.25B | 25.62% |
| 2013-01-31 | $16.43B | $4.13B | 25.13% |
| 2012-10-31 | $16.32B | $4.03B | 24.67% |
| 2012-07-31 | $16.25B | $4.22B | 25.94% |
| 2012-04-30 | $16.18B | $4.15B | 25.61% |
| 2012-01-31 | $15.86B | $3.99B | 25.15% |
| 2011-10-31 | $15.80B | $3.93B | 24.89% |
| 2011-07-31 | $15.68B | $3.64B | 23.23% |
| 2011-04-30 | $15.51B | $3.66B | 23.63% |
| 2011-01-31 | $15.30B | $4.00B | 26.13% |
| 2010-10-31 | $15.30B | $4.07B | 26.57% |
| 2010-07-31 | $15.23B | $4.42B | 29.04% |
| 2010-04-30 | $15.39B | $3.94B | 25.62% |
| 2010-01-31 | $15.45B | $2.74B | 17.75% |
| 2009-10-31 | $15.09B | $2.57B | 17.05% |
| 2009-07-31 | $14.83B | $2.09B | 14.07% |
| 2009-04-30 | $14.60B | $2.44B | 16.71% |
| 2009-01-31 | $14.63B | $3.29B | 22.48% |
| 2008-10-31 | $14.54B | $2.53B | 17.41% |
| 2008-07-31 | $14.09B | $2.78B | 19.70% |
| 2008-04-30 | $13.52B | $2.74B | 20.27% |
| 2008-01-31 | $12.94B | $2.74B | 21.16% |
| 2007-10-31 | $12.58B | $3.54B | 28.11% |
| 2007-07-31 | $12.53B | $3.58B | 28.57% |
| 2007-04-30 | $12.30B | $3.52B | 28.58% |
| 2007-01-31 | $12.09B | $3.66B | 30.27% |
| 2006-10-31 | $11.81B | $3.63B | 30.74% |
| 2006-07-31 | $11.50B | $3.48B | 30.30% |
| 2006-04-30 | $11.29B | $3.16B | 27.99% |
| 2006-01-31 | $11.00B | $2.44B | 22.18% |
| 2005-10-31 | $10.76B | $2.30B | 21.37% |
| 2005-07-31 | $10.40B | $2.29B | 22.02% |
| 2005-04-30 | $10.06B | $2.54B | 25.30% |
| 2005-01-31 | $9.94B | $3.08B | 30.97% |
| 2004-10-31 | $9.61B | $2.97B | 30.95% |
| 2004-07-31 | $9.37B | $2.90B | 30.95% |
| 2004-04-30 | $9.09B | $2.80B | 30.78% |
| 2004-01-31 | $8.57B | $2.68B | 31.26% |
| 2003-10-31 | $8.29B | $2.63B | 31.75% |
| 2003-07-31 | $8.02B | $2.44B | 30.41% |
| 2003-04-30 | $7.67B | $2.34B | 30.54% |
| 2003-01-31 | $7.31B | $2.07B | 28.28% |
| 2002-10-31 | $6.99B | $1.90B | 27.17% |
| 2002-07-31 | $6.67B | $1.63B | 24.43% |
| 2002-04-30 | $6.41B | $1.52B | 23.76% |
| 2002-01-31 | $6.14B | $1.32B | 21.56% |
| 2001-10-31 | $5.91B | $1.33B | 22.43% |
| 2001-07-31 | $5.70B | $1.57B | 27.50% |
| 2001-04-30 | $5.55B | $1.55B | 27.92% |
| 2001-01-31 | $5.47B | $1.82B | 33.21% |
| 2000-10-31 | $5.36B | $1.76B | 32.80% |
| 2000-07-31 | $5.16B | $1.68B | 32.55% |
| 2000-04-30 | $4.96B | $1.63B | 32.80% |
| 2000-01-31 | $4.67B | $1.50B | 32.13% |
| 1999-10-31 | $4.48B | $1.13B | 25.21% |
| 1999-07-31 | $4.30B | $0.97B | 22.43% |
| 1999-04-30 | $4.19B | $0.82B | 19.62% |
| 1999-01-31 | $3.73B | $0.70B | 18.89% |
| 1998-10-31 | $3.29B | $0.70B | 21.32% |
| 1998-07-31 | $2.95B | $0.70B | 23.86% |
| 1998-04-30 | $2.60B | $0.70B | 26.96% |
| 1998-01-31 | $2.56B | $0.68B | 26.57% |
| 1997-10-31 | $2.53B | $0.86B | 34.11% |
| 1997-07-31 | $2.48B | $0.84B | 33.79% |
| 1997-04-30 | $2.44B | $0.81B | 33.22% |
| 1997-01-31 | $2.40B | $0.78B | 32.48% |
| 1996-10-31 | $2.33B | $0.75B | 32.12% |
| 1996-07-31 | $2.25B | $0.71B | 31.63% |
| 1996-04-30 | $2.17B | $0.67B | 30.76% |
| 1996-01-31 | $2.09B | $0.61B | 29.16% |
| 1995-10-31 | $1.98B | $0.55B | 27.88% |
| 1995-07-31 | $1.86B | $0.50B | 26.61% |
| 1995-04-30 | $1.74B | $0.44B | 25.36% |
| 1995-01-31 | $1.62B | $0.41B | 25.32% |
| 1994-10-31 | $1.54B | $0.39B | 25.19% |
| 1994-07-31 | $1.46B | $0.37B | 25.07% |
| 1994-04-30 | $1.39B | $0.35B | 24.95% |
| 1994-01-31 | $1.36B | $0.33B | 24.48% |
| 1993-10-31 | $1.33B | $0.32B | 23.93% |
| 1993-07-31 | $1.33B | $0.32B | 24.30% |
| 1993-04-30 | $1.33B | $0.31B | 23.64% |
| 1993-01-31 | $1.30B | $0.30B | 23.01% |
| 1992-10-31 | $1.30B | $0.29B | 22.24% |
| 1992-07-31 | $1.24B | $0.26B | 20.69% |
| 1992-04-30 | $1.18B | $0.24B | 20.56% |
| 1992-01-31 | $1.13B | $0.23B | 20.56% |
| 1991-10-31 | $1.09B | $0.22B | 20.63% |
| 1991-07-31 | $1.06B | $0.21B | 19.68% |
| 1991-04-30 | $1.02B | $0.20B | 19.28% |
| 1991-01-31 | $1.00B | $0.19B | 18.84% |
| 1990-10-31 | $0.95B | $0.18B | 18.68% |
| 1990-07-31 | $0.90B | $0.17B | 19.24% |
| 1990-04-30 | $0.87B | $0.17B | 19.28% |
| 1990-01-31 | $0.82B | $0.16B | 19.22% |
| 1989-10-31 | $0.80B | $0.16B | 19.33% |
| 1989-07-31 | $0.78B | $0.15B | 19.44% |
| 1989-04-30 | $0.77B | $0.16B | 20.23% |
| 1989-01-31 | $0.73B | $0.15B | 19.92% |
| 1988-10-31 | $0.71B | $0.14B | 19.92% |
| 1988-07-31 | $0.68B | $0.14B | 20.47% |
| 1988-04-30 | $0.65B | $0.13B | 20.21% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $123.612B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $216.142B | 24.91 |
| EssilorLuxottica (ESLOY) | France | $149.893B | 0.00 |
| Boston Scientific (BSX) | United States | $139.557B | 31.91 |
| Stryker (SYK) | United States | $136.074B | 27.02 |
| Medline (MDLN) | United States | $56.293B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.245B | 0.00 |
| Agilent Technologies (A) | United States | $41.482B | 26.22 |
| GE HealthCare Technologies (GEHC) | United States | $38.615B | 18.47 |
| ResMed (RMD) | United States | $37.167B | 25.72 |
| Koninklijke Philips (PHG) | Netherlands | $28.531B | 18.64 |
| Terumo (TRUMY) | Japan | $21.128B | 23.78 |
| Insulet (PODD) | United States | $19.568B | 60.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.507B | 10.92 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.553B | 0.00 |
| Baxter (BAX) | United States | $10.101B | 8.15 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.690B | 31.25 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| BillionToOne (BLLN) | United States | $4.433B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.366B | 13.30 |
| Envista Holdings (NVST) | United States | $3.820B | 21.92 |
| Haemonetics (HAE) | United States | $3.690B | 16.42 |
| ICU Medical (ICUI) | United States | $3.661B | 23.24 |
| Prestige Consumer Healthcare (PBH) | United States | $3.111B | 14.19 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.262B | 14.54 |
| Perrigo (PRGO) | Ireland | $2.073B | 5.19 |
| Neogen (NEOG) | United States | $1.999B | 43.76 |
| LeMaitre Vascular (LMAT) | United States | $1.891B | 38.06 |
| AtriCure (ATRC) | United States | $1.810B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.784B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.742B | 76.36 |
| Phibro Animal Health (PAHC) | United States | $1.640B | 16.38 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.515B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.437B | 20.80 |
| Kestra Medical Technologies (KMTS) | United States | $1.286B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.151B | 341.43 |
| Capricor Therapeutics (CAPR) | United States | $1.133B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.054B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.028B | 0.00 |
| Omeros (OMER) | United States | $0.895B | 0.00 |
| InMode (INMD) | Israel | $0.887B | 10.02 |
| Valneva SE (VALN) | France | $0.864B | 0.00 |
| CeriBell (CBLL) | United States | $0.845B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.564B | 15.30 |
| Cerus (CERS) | United States | $0.484B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.476B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.472B | 0.00 |
| Brainsway (BWAY) | Israel | $0.467B | 79.45 |
| Canopy Growth (CGC) | Canada | $0.461B | 0.00 |
| SNDL (SNDL) | Canada | $0.434B | 0.00 |
| Evolus (EOLS) | United States | $0.371B | 0.00 |
| Quanterix (QTRX) | United States | $0.334B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.295B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 21.97 |
| Sanuwave Health (SNWV) | United States | $0.245B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.33 |
| TerrAscend (TSNDF) | Canada | $0.236B | 0.00 |
| High Tide (HITI) | Canada | $0.235B | 0.00 |
| Organigram Global (OGI) | Canada | $0.228B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.211B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.197B | 0.00 |
| Accendra Health (ACH) | United States | $0.194B | 1.95 |
| Utah Medical Products (UTMD) | United States | $0.188B | 16.54 |
| OraSure Technologies (OSUR) | United States | $0.187B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.117B | 0.00 |
| Exagen (XGN) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.76 |
| Biote (BTMD) | United States | $0.111B | 4.86 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Sharps Technology (STSS) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.58 |
| Nephros (NEPH) | United States | $0.047B | 34.00 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| Veru (VERU) | United States | $0.039B | 0.00 |
| Jin Medical (ZJYL) | China | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.57 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.014B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |